ERTS Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,463
Closed -$209K 90
2024
Q2
$209K Sell
7,463
-165
-2% -$4.54K 0.04% 87
2024
Q1
$212K Sell
7,628
-1,469
-16% -$40.8K 0.04% 86
2023
Q4
$262K Sell
9,097
-3,515
-28% -$106K 0.06% 76
2023
Q3
$418K Buy
12,612
+418
+3% +$14.8K 0.1% 48
2023
Q2
$447K Buy
12,194
+173
+1% +$6.73K 0.1% 52
2023
Q1
$490K Sell
12,021
-2,047
-15% -$88.4K 0.12% 48
2022
Q4
$721K Buy
14,068
+23
+0.2% +$1.1K 0.19% 43
2022
Q3
$615K Sell
14,045
-202
-1% -$9.82K 0.17% 40
2022
Q2
$747K Sell
14,247
-1,323
-8% -$67.4K 0.21% 38
2022
Q1
$806K Sell
15,570
-2,346
-13% -$122K 0.23% 31
2021
Q4
$1.06M Sell
17,916
-1,829
-9% -$90.6K 0.25% 31
2021
Q3
$849K Sell
19,745
-314
-2% -$13.9K 0.22% 32
2021
Q2
$786K Buy
20,059
+25
+0.1% +$972 0.21% 35
2021
Q1
$726K Buy
20,034
+429
+2% +$15.2K 0.22% 38
2020
Q4
$722K Sell
19,605
-2,360
-11% -$86.6K 0.23% 36
2020
Q3
$765K Sell
21,965
-46
-0.2% -$1.61K 0.29% 35
2020
Q2
$683K Sell
22,011
-2,705
-11% -$91.9K 0.28% 34
2020
Q1
$765K Buy
24,716
+3,156
+15% +$108K 0.37% 35
2019
Q4
$801K Sell
21,560
-31
-0.1% -$1.1K 0.36% 29
2019
Q3
$736K Buy
21,591
+6,229
+41% +$227K 0.37% 30
2019
Q2
$631K Hold
15,362
0.35% 36
2019
Q1
$619K Buy
15,362
+74
+0.5% +$2.96K 0.37% 38
2018
Q4
$633K Buy
+15,288
New +$635K 0.45% 34

Other funds holding PFE

ERTS Wealth Advisors's PFE Position: Q3 2024 in Review

ERTS Wealth Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,463 shares — an estimated $209K sold.

ERTS Wealth Advisors first reported a position in PFE in Q4 2018 and held it in 23 quarters. The position peaked at $1.06M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • ERTS Wealth Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • ERTS Wealth Advisors sold 7,463 Pfizer shares in Q3 2024, an estimated $209K.
  • ERTS Wealth Advisors first reported a position in Pfizer in Q4 2018 and held it in 23 quarters.
  • ERTS Wealth Advisors's Pfizer position peaked at $1.06M in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on ERTS Wealth Advisors's 13F filing for Q3 2024, filed 17 Oct 2024.